New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 5, 2014
17:40 EDTSNYFuture for Sanofi's contingent-value rights 'doesn't look bright', Barron's says
Sanofi's separately traded contingent-value rights will continue to drop as the value of the rights is tied to milestones and time could run out on Lemtrada, which was denied approval by the FDA, Barron's contends in its The Trader column. Reference Link
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
11:19 EDTSNYSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use